Mogamulizumab-kpkc Intravenous and Renacidin
Determining the interaction of Mogamulizumab-kpkc Intravenous and Renacidin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: citric acid / glucono-delta-lactone / magnesium carbonate topical
Brand name: Renacidin
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Renagel
- Mogamulizumab-kpkc Intravenous-Renal Caps
- Mogamulizumab-kpkc Intravenous-RenAmin
- Mogamulizumab-kpkc Intravenous-Renatabs with Iron
- Mogamulizumab-kpkc Intravenous-Renate DHA
- Mogamulizumab-kpkc Intravenous-Renese
- Renacidin-Molindone
- Renacidin-Mometasone (Oral Inhalation)
- Renacidin-Mometasone and Formoterol
- Renacidin-Mometasone and formoterol Inhalation
- Renacidin-Mometasone Cream
- Renacidin-Mometasone Furoate